Biphasic Kinetics for Rapid Onset and Sustained Release

35 concepts22 papers

When designing systems to deliver an active agent—whether it is an antibiotic in a periodontal pocket, a growth factor in a bone defect, or a therapeutic compound in an engineered patch—engineers face a fundamental kinetic conflict. A simple, single-phase delivery vehicle can typically optimize for either rapid onset or long-term maintenance, but struggles to achieve both. If a material releases its payload too quickly, it creates an immediate therapeutic effect but rapidly depletes, requiring frequent dosing and causing volatile concentration spikes. Conversely, if it releases too slowly, the system avoids depletion but fails to reach the minimum effective concentration quickly enough to be useful.

To resolve this trade-off, researchers leverage biphasic release kinetics. By decoupling the initial therapeutic onset from long-term maintenance, a single system can deliver a rapid "burst" dose followed by a controlled, prolonged release phase. This article explores the physical mechanisms that enable these dual-phase systems, how they are structured to match biological timelines, and why this kinetic pattern reflects a fundamental behavior observed across both synthetic and natural systems.


Decoupling Onset and Maintenance via Spatial Partitioning

The most direct way to force a single system to operate on two completely different timescales is spatial partitioning: separating the payload into an easily accessible surface layer and a protected internal matrix.

As HM Ji et al. demonstrate in Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac, distributing active particles both on the surface and within the internal matrix of a polymer film creates a distinct dual-phase profile. When the system is applied, the surface-bound molecules dissolve instantly into the surrounding environment, providing the rapid burst required for immediate therapeutic onset. Meanwhile, the molecules trapped deep within the matrix must slowly navigate the tortuous paths of the polymer network, establishing a long-term maintenance phase.

Biphasic Spatial Partitioning:
┌────────────────────────────────────────────────────────┐
│  ●   ●   ●   ●   Surface Layer (Immediate Burst)       │
├────────────────────────────────────────────────────────┤
│     ○       ○       ○                                  │
│  ○       ○       ○     Internal Polymer Matrix         │
│     ○       ○       ○  (Slow, Sustained Diffusion)     │
└────────────────────────────────────────────────────────┘

This process is heavily governed by the physical structure of the carrier material. In a study on electrospun nanofiber membranes, Jia‐Cheng Lv et al. show in Polycaprolactone Electrospun Nanofiber Membrane with Sustained Chlorohexidine Release Capability against Oral Pathogens that release occurs via a two-stage process. An initial rapid release from the fiber surface provides immediate localized action, which is followed by a slower, sustained release phase driven by the encapsulation within the polymer matrix as the material itself gradually degrades.


Combining Diffusion and Degradation Mechanics

Beyond simple spatial distribution, biphasic release can be engineered by combining two distinct physical phenomena: concentration-driven diffusion and structural matrix erosion.

In the early stages of delivery, the steep concentration gradient between the carrier and its environment drives rapid surface diffusion. However, as the surface payload depletes, diffusion slows down. To prevent the concentration from dropping below the therapeutic threshold, a second mechanism must take over.

As Xiangyang Xie et al. demonstrate in In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene, encapsulating payloads within biodegradable polymer microspheres achieves a consistent therapeutic window by transitioning from initial surface diffusion to bulk erosion of the polymer carrier. As water slowly penetrates the matrix, it cleaves the polymer chains. This gradual degradation of the vehicle's structural integrity steadily liberates the remaining internal payload, maintaining steady concentrations long after the initial diffusion phase has ended.


Hierarchical and Multi-Layered Architectures

To achieve even more complex, programmed timelines, researchers design hierarchical or compartmentalized architectures that isolate different components within a single device.

Hydrogel-Microsphere Composites

One powerful approach is embedding secondary carriers within a primary matrix. Ruizhi Zhang et al. engineered a dynamic scaffold for spinal cord repair in Dual-phase SilMA hydrogel: a dynamic scaffold for sequential drug release and enhanced spinal cord repair via neural differentiation and immunomodulation by embedding drug-loaded microspheres inside a bulk hydrogel matrix. The bulk hydrogel provides immediate release of therapeutic agents to address acute injury phases, while the embedded microspheres act as internal reservoirs that slowly release their contents for long-term tissue repair.

Multi-Layer Films and Sandwich Structures

When dealing with multiple or incompatible compounds, multi-layer architectures offer a way to program sequential delivery. The authors of Application of traditional Chinese medicine in film drug delivery system (Qianhang Li et al.) highlight how multi-layered film architectures allow for the sequential or programmed release of different agents within a single application. This design protects volatile or unstable compounds in internal layers while utilizing outer layers for immediate relief.

Microneedles and Nanoparticles

Hierarchy can also be used to bridge physical and chemical barriers. In Microneedle-assisted percutaneous delivery of methotrexate-loaded nanoparticles enabling sustained anti-inflammatory effects in psoriasis therapy, Hongyao Du et al. combined physical skin penetration with secondary nanoparticle encapsulation. The microneedles physically bypass the skin's outer barrier (the stratum corneum) for immediate entry, while the internal nanocarriers provide a controlled, long-term release of the agent from internal reservoirs over several days.


Matching Biological Timelines

The ultimate goal of these programmed kinetics is to match the natural, multi-stage timelines of biological healing. Tissue regeneration and disease recovery are rarely single-step processes; they require different signals at different times.

For instance, in joint and bone repair, an immediate intervention is often needed to suppress acute inflammation before long-term structural rebuilding can begin. Ze Zhao et al. note in Hydrogel-Based Microspheres for Intra-Articular Osteoarthritis Therapy: Multifunctional Carriers for Drug Delivery and Cartilage Repair: A Comprehensive Review that multi-stage sequential release employs layered or compartmentalized carrier architectures to deliver different therapeutic agents at programmed intervals, such as suppressing an inflammatory response before initiating a secondary phase of tissue repair and regeneration.

Following a similar logic, Zhi Hong Chen et al. developed composite hydrogel stents in Injectable Composite Hydrogel Stents for Bone Defect Management with Enhanced Osteogenesis and Angiogenesis. The platform is engineered for the staged release of bioactive agents, providing an initial burst of growth factors to trigger early biological processes like blood vessel formation, followed by a gradual release of mineral ions for long-term tissue maturation.

Biological Staging vs. Biphasic Release:
Timeline:      │ Acute Phase (Day 1)         │ Maturation Phase (Weeks)
───────────────┼─────────────────────────────┼────────────────────────────
Bio-Need:      │ Suppress Inflammation       │ Tissue Regeneration
Release Phase: │ Initial Rapid Burst         │ Slower, Sustained Release

This dual-phase strategy is equally vital in localized infection control. Early clinical work by Ayako SATOMI et al. in Minocycline HCl concentration in periodontal pocket after administration of LS-007. and Hiroshi Okada et al. in Topical application of the controlled release strips containing ofloxacin(PT-01) in periodontal therapy. demonstrated that high-molecular-weight polymer bases can deliver an initial high-concentration antibacterial spike to knock down local pathogens, followed by a sustained release phase to maintain therapeutic levels over several days and prevent reinfection.


A Universal Kinetic Pattern

While biphasic kinetics are heavily engineered in modern drug delivery, the underlying mathematical and physical principles are universal. The transition from a rapid, high-energy phase to a slow, stabilized phase is a fundamental property of many natural and physical systems.

In material science, for example, the escape of gas from a solid lattice follows the exact same two-stage profile. Norio Nogawa et al. show in Tritium release characteristics and hydrogen behavior in steel. that hydrogen release from metal lattices occurs in two distinct stages: an initial rapid diffusion of highly mobile, unbonded atoms is followed by a prolonged, slow release of atoms held tightly in internal trap sites.

Even the human immune system decays along a similar mathematical curve. When modeling the long-term persistence of antibodies after an infection, Jia Wei et al. found in Anti-spike antibody response to natural SARS-CoV-2 infection in the general population that biphasic exponential models capture biological decay far more accurately than single-rate models. The system exhibits a rapid initial decline as the acute immune response subsides, followed by a distinct, slower stabilization phase that maintains long-term protective immunity.

Whether dealing with diffusing molecules, escaping gas atoms, or decaying antibodies, the physical world frequently relies on biphasic kinetics to balance the competing demands of immediate response and long-term stability.

Key Foundational Work

Minocycline HCl concentration in periodontal pocket after administration of LS-007. (1987) — contributed 2 concept elements to this direction.
Topical application of the controlled release strips containing ofloxacin(PT-01) in periodontal therapy. (1988) — contributed 1 concept elements to this direction.
History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 21 papers
  2. Version 1 · 2026-10-04 · 14 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_biphasic_drug_release_9e16b377,
  title = {biphasic drug release},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/biphasic-drug-release/rdr_9e16b37787e54beba54c55b32efcd2a0},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 2, frozen text):

@misc{lacuna_biphasic_drug_release_9e16b377_v2,
  title = {biphasic drug release},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/biphasic-drug-release/rdr_9e16b37787e54beba54c55b32efcd2a0/v/2},
  note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake